Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
355
Total Claims
$728K
Drug Cost
83
Beneficiaries
$8,771
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+556%
Opioid rate vs peers
41.1% vs 6.3% avg
-36%
Cost per patient vs peers
$8,771 vs $14K avg
+29%
Brand preference vs peers
18.9% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 556% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
41.1%
Opioid Rate
146
Opioid Claims
$6,206
Opioid Cost
21.9%
Long-Acting Rate
This provider's opioid prescribing rate of 41.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 67 claims · $665K
Generic: 288 claims · $63K
Patient Profile
71
Avg Age
66%
Female
3.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About